Schedule 13G ownership disclosure

Compass Therapeutics Inc

Security class unavailable · CUSIP: 20454B104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001816338-21-000001
Form type
SC 13G/A
Filer
ANDERSON ERRIK
CIK
CIK 1816338
Filed
Dec 17, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub